IRTC - NASDAQ
iRhythm Technologies, Inc.
$104.56
+1.5%iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
At a Glance
Live SnapshotiRhythm Technologies, Inc. Profit Bridge
Profitability Analysis
Gross Margin
Exceptional pricing power and cost management. The company retains over half of revenue after direct costs.
Operating Margin
Operating losses indicate the core business is unprofitable. Requires restructuring or revenue growth.
Net Profit Margin
Net losses indicate the company is burning cash. Sustainability depends on path to profitability.
Profitability Insight
Margin squeeze alert: Healthy gross margins but weak operating margins suggest excessive operating expenses. Cost optimization could unlock significant value.
iRhythm Technologies, Inc. Income Statement
IRTC • NASDAQ
| iRhythm Technologies, Inc. Income Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
REVENUE | |||||||||||||
747.1M | 591.8M | 492.7M | 410.9M | 322.8M | 265.2M | 214.6M | 147.3M | 99.1M | 64.1M | 36.1M | 21.7M | 15.4M | |
GROSS PROFIT | |||||||||||||
(219.9M) | (184.3M) | (160.9M) | (129.3M) | (109.3M) | (70.3M) | (52.5M) | (38.8M) | (28.2M) | (20.9M) | (14.7M) | (10.6M) | (8.8M) | |
527.3M | 407.5M | 331.8M | 281.6M | 213.6M | 194.9M | 162.1M | 108.5M | 70.9M | 43.2M | 21.4M | 11.2M | 6.5M | |
OPERATING INCOME | |||||||||||||
(564.1M) | (523M) | (457M) | (395.4M) | (313.5M) | (238.6M) | (216.8M) | (154.2M) | (98.5M) | (58.8M) | (43.1M) | (25.9M) | (18.4M) | |
(479.5M) | (418.6M) | (385.6M) | (322.2M) | (274.8M) | (197.2M) | (179.5M) | (133.3M) | (85.3M) | (51.6M) | (36.7M) | (20.2M) | (14M) | |
(84.6M) | (103.8M) | (60.2M) | (46.6M) | (38.7M) | (41.3M) | (37.3M) | (20.9M) | (13.3M) | (7.2M) | (6.3M) | (5.7M) | (3.7M) | |
-36.8M | -115.5M | -125.2M | -113.8M | -99.9M | -43.7M | -54.8M | -45.7M | -27.6M | -15.6M | -21.6M | -14.8M | -11.2M | |
PRE-TAX INCOME | |||||||||||||
(13.2M) | (12.8M) | (3.7M) | (4.1M) | (1.2M) | (1.5M) | (1.6M) | (3.1M) | (3.4M) | (3.2M) | (1.1M) | (774K) | (0.0) | |
8.4M | 9.1M | 2.5M | -1.8M | -1.1M | -1.5M | -1.6M | -3.1M | -3.4M | -3.2M | -1.1M | -774K | 0.0 | |
(0.0) | (641K) | (11.1M) | (26.6M) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | |
-6.8M | 2.8M | 2.5M | -2.1M | -1.1M | 72K | 252K | -4.6M | -2.1M | -5.3M | -1.2M | -1.1M | -2.4M | |
-43.6M | -112.7M | -122.7M | -115.9M | -101M | -43.6M | -54.5M | -50.3M | -29.7M | -20.9M | -22.8M | -15.8M | -13.6M | |
NET INCOME | |||||||||||||
(953K) | (565K) | (750K) | (269K) | (367K) | (229K) | (65K) | (44K) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | |
-44.6M | -113.3M | -123.4M | -116.2M | -101.4M | -43.8M | -54.6M | -50.4M | -29.7M | -20.9M | -22.8M | -15.8M | -13.6M |
SEC Filings
IRTC - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | May 28, 2026 | May 27, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | April 30, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 30, 2026 | April 30, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | April 17, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | April 01, 2026 | March 30, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 12, 2026 | March 12, 2026 | 2026 | |
10-K 10-K 2025 FY FY | February 19, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 19, 2026 | February 19, 2026 | 2026 | |
8-K 8-K 2025 N/A | November 12, 2025 | November 12, 2025 | 2025 | |
8-K 8-K 2025 N/A | October 30, 2025 | October 30, 2025 | 2025 |
Related Guides
Continue your IRTC research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.